Internal Medicine, Hematology & Oncology · West Columbia, SC
NPI
1538198171
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
222 E Medical Ln Ste 400
West Columbia, SC, 29169
Phone (803) 794-7511
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
266,820 services
Medicare patients, 2024
1,677
Average age 75
Drug cost, 2024
$11.4M
5,402 prescriptions
Company payments, 2025
$1,409
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven A Madden was code J1439 (injection, ferric carboxymaltose, 1 mg), 54,000 times for 60 patients. In total Steven A Madden billed 266,820 services in 223 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 54,000 | 60 | $0.84 | $46K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 22,000 | 39 | $42.95 | $945K |
| J0897 Injection, denosumab, 1 mg | Office | 14,340 | 93 | $20.13 | $289K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 14,220 | 15 | $0.20 | $2,850 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 13,650 | 34 | $0.11 | $1,435 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 13,432 | 16 | $0.06 | $757 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 12,720 | 118 | $0.10 | $1,272 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 12,240 | 20 | $36.45 | $446K |
| J9299 Injection, nivolumab, 1 mg | Office | 9,500 | 12 | $24.48 | $233K |
| J0185 Injection, aprepitant, 1 mg | Office | 4,810 | 23 | $1.32 | $6,335 |
| J9267 Injection, paclitaxel, 1 mg | Office | 3,019 | 11 | $0.08 | $238 |
| 85025 Blood Count | Office | 2,405 | 828 | $7.55 | $18K |
| J9171 Injection, docetaxel, 1 mg | Office | 2,389 | 11 | $0.68 | $1,627 |
| 36415 Venipuncture Blood Collection | Office | 2,210 | 821 | $8.35 | $18K |
| J9041 Injection, bortezomib, 0.1 mg | Office | 2,168 | 15 | $1.51 | $3,280 |
By year: 2022 $5.2M for 291,987 services; 2023 $5.3M for 290,552 services; 2024 $4.9M for 266,820 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,405 | 828 | $7.55 | $18K |
| 36415 Venipuncture Blood Collection | 2,210 | 821 | $8.35 | $18K |
| 80048 Clinical Chemistry | 2,057 | 801 | $8.22 | $17K |
| 80076 Clinical Chemistry | 2,001 | 786 | $7.93 | $16K |
| 86300 Immunoassay | 428 | 210 | $20.14 | $8,622 |
| 82728 Clinical Chemistry | 367 | 181 | $13.26 | $4,866 |
| 83550 Clinical Chemistry | 314 | 164 | $8.48 | $2,663 |
| 83540 Clinical Chemistry | 314 | 164 | $6.27 | $1,970 |
| 84153 Clinical Chemistry | 247 | 99 | $17.73 | $4,378 |
| 83735 Clinical Chemistry | 216 | 80 | $6.57 | $1,419 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven A Madden prescribed most often to Medicare patients was Letrozole, with 549 prescriptions and refills. In total Steven A Madden wrote 5,402 Medicare prescriptions that cost $11.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 549 | 1,237 | 140 | $15K |
| Anastrozole Generic | 541 | 1,101 | 126 | $15K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 283 | 283 | 53 | $5,693 |
| Prednisone Generic | 229 | 271 | 56 | $1,263 |
| Eliquis Apixaban | 197 | 223 | 34 | $128K |
| Gabapentin Generic | 160 | 223 | 31 | $1,305 |
| Abiraterone Acetate Generic | 156 | 164 | 25 | $523K |
| Ondansetron Odt Ondansetron | 132 | 132 | 64 | $2,671 |
| Dexamethasone Generic | 125 | 148 | 43 | $1,224 |
| Oxycodone Hcl Generic | 121 | 121 | 26 | $1,662 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 121 | 121 | 29 | $2,127 |
| Hydroxyurea Generic | 101 | 177 | 24 | $2,187 |
| Potassium Chloride Generic | 100 | 136 | 35 | $1,103 |
| Revlimid Lenalidomide | 100 | 100 | 11 | $1.8M |
| Exemestane Generic | 97 | 189 | 27 | $11K |
Brand drugs: 937 claims; generic drugs: 4,465 claims; opioid claims: 841.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven A Madden $1,409 ($1,409 in general payments such as food, travel and fees) from 30 companies. The largest payer was Novartis Pharmaceuticals Corporation with $186.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $186 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $144 |
| Incyte Corporation INCY | 5 | $104 |
| Daiichi Sankyo Inc. 4568.T | 4 | $99.32 |
| Abbvie Inc. ABBV | 4 | $92.76 |
| Gilead Sciences, Inc. GILD | 4 | $91.49 |
| Merck Sharp & Dohme LLC MRK | 3 | $84.71 |
| Pfizer Inc. PFE | 5 | $72.6 |
| Janssen Biotech, Inc. JNJ | 4 | $72.56 |
| Celgene Corporation BMY | 3 | $61.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.